Dagmara Hering
Overview
Explore the profile of Dagmara Hering including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
117
Citations
2132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dimitriadis K, Iliakis P, Vakka A, Pyrpyris N, Pitsillidi A, Tsioufis P, et al.
Cardiol Rev
. 2025 Jan;
PMID: 39750025
Although metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed nonalcoholic fatty liver disease, has become the most common chronic liver disorder, its complex pathophysiology has not been fully elucidated up...
2.
Dimitriadis K, Iliakis P, Pyrpyris N, Tatakis F, Fragkoulis C, Mantziaris V, et al.
J Clin Med
. 2024 Nov;
13(22).
PMID: 39597800
Renal denervation (RDN), a transcatheter renal sympathetic nerve ablation procedure, is a relatively novel established procedure for the treatment of hypertension, with it being recognized as a third option for...
3.
Cierpka-Kmiec K, Khursa R, Hering D
J Clin Hypertens (Greenwich)
. 2024 Sep;
26(12):1391-1401.
PMID: 39276133
Classic and non-classic cardiovascular (CV) risk factors accumulate in chronic kidney disease (CKD), contributing to vascular remodeling and hemodynamic abnormalities. This study aimed to determine hemodynamic phenotypes based on linear...
4.
Merks P, Chelstowska B, Religioni U, Neumann-Podczaska A, Krasinski Z, Kobayashi A, et al.
Med Sci Monit
. 2024 Mar;
30:e942923.
PMID: 38431771
New Medicine Service (NMS) components are an important element to improve patient compliance with medical recommendations. NMS provides support to patients prescribed new medicines, helping them to manage long-term conditions....
5.
Wileczek A, Stodolkiewicz-Nowarska E, Reichert A, Kustron A, Sledz J, Biernikiewicz W, et al.
Kardiol Pol
. 2023 Nov;
81(12):1272-1275.
PMID: 37997826
No abstract available.
6.
Weber M, Hering D, Nikoleishvili D, Imedadze A, Dughashvili G, Klimiashvili Z, et al.
Am J Nephrol
. 2023 Aug;
55(3):319-328.
PMID: 37651994
Introduction: We previously completed a trial of renal pelvic denervation for treating hypertension that reduced blood pressure by the 2-month primary endpoint. However, information on the durability of effectiveness is...
7.
Yaneva-Sirakova T, Coca A, Sierra C, Cunha P, Hering D
Blood Press
. 2023 Jul;
32(1):2237129.
PMID: 37477278
No abstract available.
8.
Hering D, Narkiewicz K
Blood Press
. 2023 Jul;
32(1):2232873.
PMID: 37470450
Uncontrolled hypertension drives the global burden of increased cardiovascular disease (CVD) morbidity and mortality. Although high blood pressure (BP) is treatable and preventable, only half of the patients with hypertension...
9.
Noreen N, Bashir F, Khan A, Safi M, Lashari W, Hering D
Prev Chronic Dis
. 2023 May;
20:E42.
PMID: 37229649
Introduction: Medication nonadherence leads to poor health outcomes, frequent complications, and high economic impact. Our objective was to assess the determinants of adherence to medication regimens among patients with hypertension....
10.
Yaneva-Sirakova T, Petrov I, Traykov L, Coca A, Cunha P, Gasecki D, et al.
Blood Press
. 2023 May;
32(1):2208228.
PMID: 37209040
No abstract available.